Arvinas (ARVN) Cash & Equivalents (2017 - 2026)

Arvinas' (ARVN) quarterly Cash & Equivalents came in at $87.3 million in Q1 2026, up 7.78% year-on-year from $81.0 million in Q1 2025, and down 38.91% quarter-over-quarter from $142.9 million in Q4 2025.

Arvinas (ARVN) Cash & Equivalents (2017 - 2026) Analysis & Trends

Arvinas' Cash & Equivalents history runs 10 years deep, the most recent figure standing at $87.3 million for Q1 2026.

  • On a quarterly basis, Cash & Equivalents rose 7.78% year-over-year to $87.3 million in Q1 2026; TTM through Mar 2026 was $87.3 million, a 7.78% increase from a year earlier, with the FY2025 full-year figure at $142.9 million, up 42.19% from the prior year.
  • Cash & Equivalents declined to $87.3 million in Q1 2026 per ARVN's latest filing, from $142.9 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $311.7 million in Q4 2023 and bottomed at $62.3 million in Q1 2022.
  • The 5-year median for Cash & Equivalents is $100.5 million (2024), against an average of $116.0 million.
  • Across the five-year window, Cash & Equivalents tumbled 82.0% in 2022 and surged 283.39% in 2023, its largest moves.
  • Year by year, Cash & Equivalents stood at $81.3 million in 2022, then jumped by 283.39% to $311.7 million in 2023, then sank by 67.76% to $100.5 million in 2024, then soared by 42.19% to $142.9 million in 2025, then plunged by 38.91% to $87.3 million in 2026.
  • Per Business Quant, the three latest ARVN Cash & Equivalents figures stand at $87.3 million (Q1 2026), $142.9 million (Q4 2025), and $101.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 82.45 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 61.40 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 4.79 Bn
4 NuCana 279.75 Bn 279.75 Bn - 32.26 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 5.49 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.96 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 3.58 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 440.94 Mn
10 Arvinas 519.68 Mn -95.22 Mn - 87.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 87.30 Mn
Dec 31, 2025 142.90 Mn
Sep 30, 2025 101.50 Mn
Jun 30, 2025 114.90 Mn
Mar 31, 2025 81.00 Mn
Dec 31, 2024 100.50 Mn
Sep 30, 2024 85.20 Mn
Jun 30, 2024 154.80 Mn
Mar 31, 2024 88.00 Mn
Dec 31, 2023 311.70 Mn
Sep 30, 2023 113.70 Mn
Jun 30, 2023 90.60 Mn
Mar 31, 2023 130.20 Mn
Dec 31, 2022 81.30 Mn
Sep 30, 2022 132.60 Mn
Jun 30, 2022 93.20 Mn
Mar 31, 2022 62.30 Mn
Dec 31, 2021 108.30 Mn
Sep 30, 2021 255.66 Mn
Jun 30, 2021 48.73 Mn